フジワラ アツシ
Atsushi Fujiwara
藤原 篤之 所属 川崎医療福祉大学 リハビリテーション学部 視能療法学科 職種 講師 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy. |
掲載誌名 | 正式名:PloS one 略 称:PLoS One ISSNコード:19326203/19326203 |
掲載区分 | 国外 |
巻・号・頁 | 12(7),pp.e0181550 |
著者・共著者 | Miki Takako, Naito Tomoko, Fujiwara Miyuki, Araki Ryoichi, Kiyoi Rieko, Shiode Yusuke, Fujiwara Atsushi, Morizane Yuki, Shiraga Fumio |
発行年月 | 2017 |
概要 | For primary open angle glaucoma (POAG), laser treatment or surgery is used when the target intraocular pressure (IOP) cannot be achieved by pharmacological agents, such as prostaglandin (PG) analogs; these drugs also have varied effects. We retrospectively reviewed the medical records of 74 POAG patients (74 eyes) whose IOP was inadequately controlled by PG analogs (bimatoprost [13 eyes], latanoprost [34 eyes], tafluprost [11 eyes], and travoprost [16 eyes]) and underwent primary trabeculectomy. The proportion of patients with no recurrent IOP elevation within 24 months post-trabeculectomy was significantly (P < 0.001) lower in the bimatoprost group (31.3%) than in the latanoprost (83.2%), tafluprost (45.5%), or travoprost groups (65.6%). Deepening of the upper eyelid sulcus (DUES) was observed before trabeculectomy in 18 of 74 eyes (24.3%) treated with bimatoprost (9 eyes; 50.0%), latanoprost (3 eyes; 16.7%), tafluprost (1 eye; 5.5%) and travoprost (5 eyes; 27.8%). The proportion of patients with no recurrent IOP elevation up to 24 months post-trabeculectomy was significantly (P < 0.0001) lower in the DUES(+) group (34.7%) than in the DUES(-) group (74.3%). Multivariate stepwise logistic regression analysis, with no recurrent IOP elevation used as dependent variable, and bimatoprost, latanoprost, travoprost, tafluprost, β-blocker, carbonic anhydrase inhibitor, brimonidine, gender, age, preoperative IOP, mean deviation, duration of PG analog use before surgery, and the number of ophthalmic solutions used as independent variables, identified only bimatoprost as a significant independent factor (P = 0.0368). |
DOI | 10.1371/journal.pone.0181550 |
PMID | 28727804 |